Mumbai: Yashoda Medicity, a leading healthcare institution recognised for its excellence in patient care, has partnered with ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

USA: A new joint clinical practice guideline from the Endocrine Society and the European Society of Endocrinology, published ...

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

USA: A recent analysis from the AZALEA-TIMI 71 trial, published in the Journal of the American College of Cardiology (JACC), ...

Raritan: Johnson & Johnson has received priority review from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) filed for TAR-200, an intravesical gemcitabine ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended key ...

The study used data from 759 adults participating in the U.S. National Health and Nutrition Examination Survey (NHANES) ...

Led by Dr. Mostafa M. Baraka from the Division of Pediatric Orthopedics, Ain Shams University, Cairo, Egypt, the research ...

Recent study examines the implications of multiple cycles of controlled ovarian stimulation (COS) using supraphysiologic ...

An Aston University optometrist, Professor James Wolffsohn, has determined an optimum blinking exercise routine for people ...

Researchers have found in a new cohort study that higher exposure to anticholinergic medications was associated with an accelerated decline in physical performance. This decline was ...